Buy Gilead Sciences Real Money Pro($)

Its prospects exploded with a breakthrough drug.
For speculative investors.
The CEO of Allergan has created value for shareholders.

Shotgun Investing in Biotech Real Money Pro($)

Two speculative plays are worthy of consideration.

The Fibocall: Celgene Real Money Pro($)

This beloved stock has triggered a long-term overbought signal again.

Invest in a Healthy Liver Real Money Pro($)

Drugs for liver diseases are good opportunities.
Some growth leaders in the sector are getting technical support.
Try the Peter Lynch technique in picking stocks.
The next step is to know how much risk you can bear.

The Fibocall: Merck Real Money Pro($)

Look to be a small buyer now that shares triggered a long-term oversold signal.

Columnist Conversations

AAPL needs to clear this hurdle IF this last low is any good!! View Chart » ...
The Fed didn't raise interest rates, but the market did via lower bond and note prices. The recent run in Trea...
WHR has regained all the of the ground lost over the last nine sessions during today's rip higher. The st...
Just to let you know, the three dissents come from governors who will not be voting members in 2015. Fisher i...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.